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There is a great paucity of information about Helicobacter pylori infection in the countries of
the Caribbean basin. Almost no studies have been performed to determine the prevalence,
antibiotic resistance or virulence factors of the bacterium. To measure the prevalence of H.
pylori infection among patients attending endoscopy in three clinics in Havana, Cuba, to
evaluate clarithromycin resistance, and to determine the cagA status of the strains obtained.
Endoscopy was performed and biopsies were obtained from 117 successive patients attending
the Institute of Oncology, the Institute of Gastroenterology, and the Calixto Garcia Hospital in
Havana, Cuba. Biopsies were maintained at –70 ºC before being cultured on three different
media (two selective and one non-selective) and incubated for 7 days at 37 °C under a
microaerobic atmosphere. The presence of H. pylori was identified by oxidase, catalase and
urease activities. DNA was extracted, and PCR was performed with primers H2761676 which
amplify a 397 bp fragment of the cagA gene. Clarithromycin susceptibility was measured by
the gel diffusion method. The diagnoses of patients were: 1 gastric carcinoma; 19 duodenal
ulcers; 8 gastric ulcers; and 89 non-ulcer dyspepsia, including (62) gastritis, (9) hiatal
hernia,(2) biliary reflux, (1) gastric polyps, and (15) no abnormality. Among the 117 biopsies
tested, 83 were H. pylori positive  (70.9%). The cagA status determined for 35 cases gave a
positive result in 31 cases (88.5%). Only 3% of the strains were resistant to clarithromycin.
The prevalence of Helicobacter pylori infection in the symptomatic population of La Habana is
the same as reported for other developing countries. Most strains were cagA positive and are
likely harbour the cag pathogenicity island. The low resistance to clarithromycin in the strains
studied probably reflects the low degree of use of the antibiotic in this population.
Keywords: H. pylori, prevalence, endoscopic diagnosis
Introduction 
The infection caused by Helicobacter pylori plays
an important role in the development of several
digestive diseases and it has a worldwide
distribution and is significantly more frequent in
developing countries than in industrialized country.
This microorganism has been recently accepted as
related to active chronic gastritis, peptic disease
(both gastric and duodenal ones), gastric
adenocarcinoma and gastric lymphoma type MALT
(1-5). The phenotype and genotype study of
Helicobacter pylori include putative bacterial
virulence factors. The most common bacterial
virulence factors studies are the cag pathogenicity
island, for which cagA is a marker and the
vacuolating cytotoxin VacA (6-8). Few studies
have been performed in the Caribbean to
determine the prevalence of Helicobacter pylori
infection and to get an insight into the type of
strains which are circulating (9-12).
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Our aims were
 To determine the prevalence of H. pylori
infection among patients attending endoscopy
clinic in Cuba. 
 To evaluate the cagA status of the strains
obtained.
 To evaluate clarithromycin susceptibility.
Material & Methods 
Biopsy specimens: We examined H. pylori strain
isolated from 117 patients who were subjected to
upper gastrointestinal endoscopy for clinical
reasons at the Institute of Oncology, the Institute
of Gastroenterology and Calixto García Hospital in
Havana, Cuba. Patients had the following
endoscopic diagnosis: gastric carcinoma (1);
duodenal ulcer (19); gastric ulcer (8); non ulcer
dyspepsia: 89 including erosive gastritis (62),
hiatal hernia (9), biliary reflux (2 ), gastric polyps
(1), no abnormality (15).  All patients signed
informed consent. During the endoscopic
procedure three biopsy specimen (two the antrum
and one from the corpus) and were maintained at
-70ºC before being cultured.
Culture of H. pylori: Biopsies specimens were
placed in 0.5 mL of Brucella broth (Biomérieux)
and homogenized with an electric tissue
homogeniser Ultraturax; LaboModerne, Paris,
France for 30s. Aliquots were placed for isolation
on each of three different media (selective in
house medium, pylori Agar Biomérieux, Marcy L
’Etoile, France), and a non-selective Columbia
medium (Oxoid Unipath, Basingstoke, Hants,UK)
enriched with 10% human blood. All media were
incubated for 7 days at 37 ºC in a microaerobic
atmosphere. They were identified by colony
morfology, oxidase, catalase and urease activities.
Clarithromycin susceptibility was measured by the
gel diffusion method. Table 1 (13-19).
DNA extraction: A pool of colonies obtained from
35 patients were transferred to a microcentrifuge
tube that contained 500 µl of sterile distilled water
and centrifugated for five min at 10 000 g. The
pellet was resuspended in 300 µl of extraction
buffer (20 µM Tris/HCL,pH 8, 0.5% Tween 20)
and proteinase K was added at final concentration
of 0.5 µg/mL. The mixture was incubated at 55 ºC
for one hour. Finally the enzyme was inactivated
by heating the sample for 10 minutes at 98 ºC
(20).
cagA gene detection: Primers used for cagA
typing were H276/676. For PCR of each sample,
the mixture contained 25 pmol of each primer,
100 ng of genomic DNA, each deoxynucleoside
triphosfate at a concentration of 100 µM, and 1U
of Taq DNA. The reactions were performed in an
automated DNA thermal cycler, with 30 cycles of
denaturation 94 ºC for 1 min, annealing at 52 ºC
for 1 min, and extension at 72 ºC for 2 min
(21,22).
PCR product detection: All amplified PCR products
were resolved in 0.8% agarose gels, stained with
ethidium bromide and detected under a short -
wavelength UV Light source. We consider strain
cagA positive when it show a product of 397 bp
fragment in PCR reaction (22-24). 
Results & Discussion
H. pylori status of the Cuban population has not
been explored. Endoscopy was performed and
biopsies were obtained from 117 successive
patients attending the Institute of Oncology, the
Institute of Gastroenterology, and the Calixto
García Hospital in Havana, Cuba. Biopsies were
maintained at –70 °C before being cultured on
three different media ( two selective and one non-
selective) and incubated for 7 days at 37 °C
under a microaerobic atmosphere. The presence of
H. pylori was identified by oxidase, catalase and
urease activities. DNA was extracted, and PCR
was performed with primers H276/676 which
amplify a 397 bp fragment of the cagA gene.
Clarithromycin susceptibility was measured by the
gel diffusion method. The diagnoses of patients
were: 1 gastric carcinoma; 19 duodenal ulcers; 8
gastric ulcers; and 89 non-ulcer dyspepsia,
including (62) gastritis, (9) hiatal hernia, (2) biliary
reflux, (1) gastric polyps, and (15) no abnormality.
Among the 117 biopsies tested, 83 were H. pylori
positive (70.9%). The cagA status determined for
35 cases gave a positive result in 31 cases
(88.5%). Only 3% of the strains were resistant to
clarithromycin (Table 1-2).
The prevalence of H. pylori infection in the
symptomatic population of La Habana is the same
as reported of other developing countries (9-12).
Most strains were cagA positive and are likely
harbour the cag pathogenicity island (Tabla 2).The
low resistant to clarithromycin in the strains
studied probably reflects the low degree of use of
the antibiotic in this population (25-27).
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Table 1. Growth of Helicobacter pylori isolated
from biopsy specimens on direct culture
















Table 2. Genotype cagA  from Cuban isolated of
Helicobacter pylori

















 The prevalence of Helicobacter pylori infection
in the symptomatic population of  La Habana
is the same as reported for other developing
countries.
 Among the 117 biopsies tested, 83 were
positive (70.9%).
 The cagA status determined for 35 cases gave
a positive result in 31 cases (88.5%).
 Most strains were cagA positive and are likely
harbour the cagA pathogenicity island. 
 The low resistance to clarithromycin in the
strains studied probably reflects the low
degree of use of the antibiotic in this
population.
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Infección por Helicobacter pylori en la Ciudad de La Habana, Cuba. Prevalencia de las
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Resumen
Existe una gran falta de información acerca de la infección por Helicobacter pylori en los países de la
región del Caribe. Nuestros objetivos en este estudio fueron determinar la prevalencia, la resistencia a
los antibióticos y los factores de virulencia de la bacteria. La medida de la prevalencia de la infección
por H. pylori se determinó en un grupo de pacientes a los que se les practicó una endoscopia en tres
centros hospitalarios de La Ciudad de La Habana, lo que nos permitió evaluar la resistencia a la
claritromicina y la presencia de cagA + en las cepas obtenidas. De las endoscopias realizadas se
obtuvieron 117 biopsias gástricas, procedentes de tres centros hospitalarios de La Ciudad de La
Habana, Cuba: Instituto de Oncología, Instituto de Gastroenterología y el Hospital Calixto García. Las
biopsias fueron mantenidas a –70 ºC para posterior cultivo en tres medios diferentes (dos selectivos y
uno no selectivo) y su posterior incubación por 7 días a 37 ºC en una atmósfera de microaerofilia. La
presencia de H. pylori fue identificada por la presencia de diferentes enzimas (oxidasa, catalasa,
ureasa). Se realizó la extracción del DNA y la PCR, donde se utilizó el primer H2761676 y se amplificó
con 397 fragmentos del gen cagA. La susceptibilidad a la claritromicina fue medida por el método de
difusión en gel. Diagnóstico endoscópico: (1) cáncer gástrico; (19) úlcera duodenal; (8) úlcera gástrica;
(89) dispepsias no ulcerosas, incluyendo (62) gastritis; (9) hernia hiatal; (2) reflujo biliar; (1) pólipo
gástrico; (15) panendoscopias normales. Del total de 117 biopsias realizadas, 83 fueron positivas a la
infección por H.pylori (70,9% ). De las 35 cepas a las que se les realizó presencia de cagA+ resultaron
positivas 31 (88,5%). Solo el 3% de las cepas fueron resistentes a la claritromicina. La prevalencia de
la infección por H. pylori en la población sintomática de La Ciudad de La Habana es la misma que la
reportada en países desarrollados. La mayoría de las cepas fueron cagA positivas y son probablemente
el puerto de la Isla de patogenicidad (cagPAI). La baja resistencia  a la claritromicina en las cepas
estudiadas, probablemente refleja la escasa utilización de este antibiótico en la población estudiada.
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